珠海都市网
您当前的位置 :首页 > 文传商讯 > 正文
Sinovac Amends Shareholder Rights Plan
2024年02月23日 16:43:52来源:作者:
【摘要】 文传商讯,中国领先的新闻稿来源,由国际文传(中国)电讯社携手美国商业资讯对外提供。帮助美国商业资讯将其客户的新闻稿呈现给大中华区的目标受众,每日提供由国际文传专业记者团队报导的有关这些行业的中文新闻

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its shareholder rights plan. The amendment extends the expiration date of the plan from February 22, 2024 to February 22, 2025.

About SINOVAC

Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of biomedical products that protect against human infectious diseases.

SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, mumps, etc.

The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and commercialized in China in 2016. In 2022, SINOVAC’s Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO.

SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program.

SINOVAC continually dedicates itself to pipeline development including but not limited to new technology, new vaccines as well as other biomedical products. We will constantly explore global opportunities of strategic expansion.

For more information, please visit the Company’s website at www.sinovac.com.

责任编辑: admin

看新闻,关注新闻

搜狐网友:m/m  没心没肺°
评论:有些人,认真的让你心疼,有些人,欠扁的让你牙疼

猫扑网友:夏花一般绚烂
评论:八戒,别以为你站在路灯下就是夜明猪了

百度网友:自戀的病源
评论:世界上最远的距离不是生与死,而是我在新浪微博,而你却在腾讯微博。

腾讯网友:情是无所不为
评论:你都好意思骗我了,我哪好意思不信。

天涯网友:我跟了这节奏
评论:我以前对你掏心掏肺 你却对我狼心狗肺 搞得我现在没心没肺

其它网友:昔年 °Cold
评论:有没有一个女生会对我这样说:“别装了,我知道你喜欢我”

本网网友:迷°Corrid丶
评论:人生如同故事,重要的并不是有多长,而是在有多好。

淘宝网友:独白   song
评论:连贝克汉姆都不知道,你丫还有什么资格敢跟我谈篮球

网易网友:不懂得挽留ゝ
评论:> 有人争取,就会有人失去

天猫网友:m/m  撕心裂肺°
评论:女人最恨的男人是陈世美;男人最喜欢的女人是潘金莲。

相关阅读
分享到:
版权和免责申明

珠海都市网所有文字、图片、视频、音频等资料均来自互联网,不代表本站赞同其观点,本站亦不为其版权负责。相关作品的原创性、文中陈述文字以及内容数据庞杂本站无法一一核实,如果您发现本网站上有侵犯您的合法权益的内容,请联系我们,本网站将立即予以删除!